Oral signs in juvenile dermatomyositis
DOI:
https://doi.org/10.5935/2525-5711.20170027Palavras-chave:
Dermatomyositis, Telangiectasis, Gingiva, Mouth MucosaResumo
Juvenile Dermatomyositis (JDM) is a severe inflammatory myopathy characterized by multisystemic vasculopathy during childhood. The general profile consists of symmetric proximal muscle weakness and the presence of characteristic rashes. This case describes an 11-year-old girl with hyperplastic gingival inflammation, telangiectasia and lichenoid retroalveolar striae detected by dental examination visit, when she also showed rash and papules in her hands. Histopathological diagnosis of the retroalveolar mucosa was indica- tive of unspecific chronic inflammation. Later when muscle symptoms and serum changes were present the JDM diagnosis was confirmed. The patient was successfully treated with systemic corticosteroids and regular professional dental cleaning. In order to get an early diagnosis and effective treatment for the patients, it is important that oral health care providers are aware of the oral manifestations related to systemic diseases, such as JDM.
Referências
Gowdie PJ, Allen RC, Kornberg AJ, Akikusa JD. Clinical features and disease course of patients with juvenile dermatomyositis. Int J Rheum Dis. 2013;16:561-7.
Almeida B, Campanilho-Marques R, Arnold K, Pilkington CA, Wedderburn LR, Nistala K; Juvenile Dermatomyositis Research Group. Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated. Arthritis Rheumatol. 2015;67:2495-502.
Khanna S, Reed AM. Immunopathogenesis of juvenile dermatomyositis. Muscle Nerve. 2010;41:581-92.
Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, Nakano N, et al. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford). 2015;54:784-91.
Ghali FE, Stein LD, Fine JD, Burkes EJ, McCauliffe DP. Gingival telangiectasia: an underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol. 1999;135:1370-4.
Savioli C, Silva CA, Fabri GM, Kozu K, Campos LM, Bonfá E, et al. Gingival capillary changes and oral motor weakness in juvenile dermatomyositis. Rheumatology (Oxford). 2010;49:1962-70.
Gonçalves LM, Bezerra-Júnior JR, Gordón-Núñez MA, Libério SA, de Fátima Vasconcelos Pereira A, da Cruz MC. Oral manifestations as important symptoms for juvenile dermatomyositis early diagnosis: a case report. Int J Paediatr Dent. 2011;21:77-80.
Rider LG, Atkinson JC. Images in clinical medicine. Gingival and periungual vasculopathy of juvenile dermatomyositis. N Engl J Med. 2009;360:e21.
Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2.
Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al.; NIAMS Juvenile DM Registry Physician Referral Group. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49:300-5.
Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol. 1995;34:732-6.
Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, et al.; UK Juvenile Dermatomyositis Research Group. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis. 2015;74:204-10.
Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum. 2000;43:541-9.
McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al.; Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. Rheumatology (Oxford). 2006;45:1255-60.
Sallum AM, Kiss MH, Sachetti S, Resende MB, Moutinho KC, Carvalho Mde S, et al. Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr. 2002;60:889-99.
Sun C, Lee JH, Yang YH, Yu HH, Wang LC, Lin YT, et al. Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes. Pediatr Neonatol. 2015;56:31-9.
Patwardhan A, Rennebohm R, Dvorchik I, Spencer CH. Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center's experience. Pediatr Rheumatol Online J. 2012;10:34.
Kishi T, Miyamae T, Hara R, Nakajima S, Imagawa T, Mori M, et al. Clinical analysis of 50 children with juvenile dermatomyositis. Mod Rheumatol. 2013;23:311-7.
Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2013;39:877-904.
Rider LG, Nistala K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J Intern Med. 2016;280:24-38.
Malek A, Raeeskarami SR, Ziaee V, Aghighi Y, Moradinejad MH. Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis. Clin Rheumatol. 2014;33:1113-8.
Sánchez Carbonell M, Climent Antolí H, Leandro Fonseca AL, Paricio Talayero JM, Escrivá Tomás P. Dermatomyositis. Presentation of a mild to moderate case with early dysphagia. An Pediatr. 2015;82:e86-9.
Ferreira Dde C, Dos Santos KR, Herdy GV. Oral chronic hyperplastic candidiasis associated with juvenile dermatomyositis. Rev Soc Bras Med Trop. 2012;45:540.
Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A. Anasarca: not a nephrotic syndrome but dermatomyositis. Eur J Pediatr. 2008;167:831-4.
Holmes MV, Ioannou Y, Borysiewicz C, Sen D. Juvenile dermatomyositis with Sjögren's syndrome. Clin Rheumatol. 2008;27:S3-5.
Sarifakioglu N, Terzioglu A, Ates L, Bingül F, Aslan G. Bilateral symmetric mandibular calcified nodules related to juvenile dermatomyositis. J Oral Maxillofac Surg. 2003;61:527.
Mitchell JP, Dennis GJ, Rider LG. Juvenile dermatomyositis presenting with anasarca: A possible indicator of severe disease activity. J Pediatr. 2001;138:942-5.
Geist SM, Tanaka TI. Oral lichen planus in a dermatomyositis patient that resolved after intravenous immunoglobulin therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e111-4.
Callen JP. Oral manifestation of collagen vascular disease. Semi Cutan Med Surg. 1997;16:323-7.
Healy CM, Tobin AM, Kirby B, Flint SR. Oral lesions as an initial manifestation of dermatomyositis with occult malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:184-7.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
